Register for the 2024 Personnel Placement Service (PPS) to request an interview.

Details

Posted: 17-Oct-24

Location: New York, New York

Type: Residency PGY-2

Salary: 65,000

Categories:

Graduate Program

Pharmacy

Job Setting:

Hospital/Institutional

Requirements:

Residency Required

Specialty Practice Areas:

Oncology

Salary Details:

An additional housing allowance of approximately $13,300 is provided for each pharmacy resident.

Required Education:

PharmD

Additional Information:

2 openings available.

The MSK PGY2 Oncology Residency training builds on the foundations of pharmacy practice established during Doctor of Pharmacy (PharmD) education and the PGY1 pharmacy residency experience. The MSK PGY2 Oncology Residency provides residents with a 12 month learning experience that prepares them to function independently as a clinical pharmacy practitioner in oncology, to serve as a fully integrated member of a multi-disciplinary team, and to optimize medications used in the provision of cancer care. Residents who successfully complete a PGY2 Oncology Residency at MSK will possess competencies that prepare them for future clinical, research or academic positions, leadership roles in oncology, and board certification in oncology pharmacy.

The adult oncology specialty residency provides advanced training in clinical therapeutics for the adult cancer patient. The main objectives of this comprehensive one-year residency program are to:

1. Establish a firm knowledge-base regarding adult malignancies, treatment options, and antineoplastic pharmacology, pharmacokinetics, and pharmacodynamics
2. Develop and build the knowledge and clinical skills required to practice as an independent oncology pharmacy practitioner
3. Foster development of critical thinking and literature evaluation skills 
4. Provide an introduction to clinical research

Rotations include, but are not limited to, Leukemia, Lymphoma, Bone Marrow Transplant, Multiple Myeloma, Cellular Therapy Service, Neuro-oncology, Gastrointestinal Cancer (Outpatient), Gynecologic Malignancies (Outpatient), Genitourinary Malignancies (Outpatient), Breast Cancer (Outpatient), Pediatric Oncology, Infectious Diseases, Early Drug Development (Phase I Clinic), Thoracic Malignancies, Melanoma, and Investigational Drug Services. Residents will also develop skills for continuous professional development through the required completion of a clinical research project, clinical and didactic presentations, journal clubs, and other educational offerings. The residency program is supported by board certified preceptors, pharmacy staff, and administration.

Requirements for consideration in the program include:

1. PharmD Degree
2. Completion of an ASHP accredited PGY1 residency program
3. Eligibility for Pharmacy licensure in NY State

Interested applicants will be required to submit the following through PhORCAS: Curriculum Vitae, Letter of Interest, three Letters of Recommendation and Official Academic Transcripts.  Interviews are scheduled on a rolling basis, therefore early submission of applications is encouraged.

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s oldest, largest, and most respected comprehensive centers devoted exclusively to cancer. We have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years. We have dedicated more than a century to patient care and innovative research. When you work within our organization, you will be part of a team with a purpose. You will be encouraged to learn and grow through responsibility and collaboration. Most importantly, you will contribute to the fulfillment of our mission: the progressive control and cure of cancer through our pillars of comprehensive patient care, research, and education.

Connections working at Memorial Sloan Kettering Cancer Center